Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 7/20 | 0.45 |
| ▸ | ATR | Q13535 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TYK2 | P29597 | 6/20 | 0.43 |
| ▸ | JAK2 | O60674 | 5/20 | 0.43 |
| ▸ | JAK1 | P23458 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | CGAS | Q8N884 | 1/20 | 0.40 |
| ▸ | CHUK | O15111 | 1/20 | 0.38 |
| ▸ | ICOSLG | O75144 | 1/20 | 0.38 |
| ▸ | ICOS | Q9Y6W8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6538101 | 0.90 | CYP3A4 (0.46) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6537494 | 0.90 | CD38 (0.46) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6537488 | 0.89 | CYP3A4 (0.48) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6537639 | 0.88 | CD38 (0.46) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6537819 | 0.81 | CYP3A4 (0.45) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6537684 | 0.81 | CYP3A4 (0.48) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6536783 | 0.81 | TYK2 (0.53) | TYK2JAK2JAK1CYP3A4 | |
| SCHEMBL6537943 | 0.81 | CYP3A4 (0.47) | CD38ATRMEN1KMT2ATYK2 | |
| SCHEMBL6538007 | 0.79 | CYP3A4 (0.43) | CD38ATRKMT2ATYK2JAK2 | |
| SCHEMBL6538092 | 0.79 | CD38 (0.50) | CD38ATRMEN1KMT2ATYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0876345-B1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-08-18 | — | — | EP | disclosed |
| US-6008230-A | TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0876345-A1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997014681-A1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-24 | — | — | WO | disclosed |